sylatron
Showing 1 - 1 of 1
Advanced Cholangiocarcinoma Trial in Washington (Pembrolizumab, Sylatron)
Terminated
- Advanced Cholangiocarcinoma
- Pembrolizumab
- Sylatron
-
Washington, District of ColumbiaGeorgetown Lombardi Comprehensive Cancer Center
Feb 14, 2022